Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,434
Closed -$693K 109
2017
Q1
$693K Hold
11,434
0.01% 96
2016
Q4
$642K Hold
11,434
0.01% 98
2016
Q3
$681K Hold
11,434
0.01% 89
2016
Q2
$628K Hold
11,434
0.01% 92
2016
Q1
$577K Hold
11,434
0.01% 95
2015
Q4
$576K Hold
11,434
0.01% 96
2015
Q3
$538K Hold
11,434
0.01% 98
2015
Q2
$621K Hold
11,434
0.01% 96
2015
Q1
$627K Hold
11,434
0.01% 96
2014
Q4
$620K Hold
11,434
0.01% 96
2014
Q3
$646K Hold
11,434
0.01% 96
2014
Q2
$631K Hold
11,434
0.01% 89
2014
Q1
$619K Hold
11,434
0.01% 90
2013
Q4
$547K Buy
11,434
+220
+2% +$10.1K 0.01% 92
2013
Q3
$509K Hold
11,214
0.01% 90
2013
Q2
$497K Buy
+11,214
New +$501K 0.01% 91

Other funds holding MRK

Cooke & Bieler's MRK Position: Q2 2017 in Review

Cooke & Bieler sold out of Merck (MRK) in Q2 2017, closing a stake of 11,434 shares — an estimated $693K sold.

Cooke & Bieler first reported a position in MRK in Q2 2013 and held it in 16 quarters. The position peaked at $693K in Q1 2017. 1,926 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Cooke & Bieler reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
  • Cooke & Bieler sold 11,434 Merck shares in Q2 2017, an estimated $693K.
  • Cooke & Bieler first reported a position in Merck in Q2 2013 and held it in 16 quarters.
  • Cooke & Bieler's Merck position peaked at $693K in Q1 2017.
  • 1,926 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Cooke & Bieler's 13F filing for Q2 2017, filed 4 Aug 2017.